Protein synthesis by chemical ligation of unprotected peptides in aqueous solution

Methods in Enzymology

Volumn 289, Issue , 1997, Pages 266-298

  Muir, Tom W ^a   Dawson, Philip E ^a   Kent, Stephen B H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AQUEOUS SOLUTION; ARTICLE; CRYSTAL STRUCTURE; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; LIGATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030711495     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(97)89052-0     Document Type: Article

References (47)

1. M. Schnölzer and S. B. H. Kent, Science 256, 221 (1992).
2. A. Nefzi, X. Sun, and M. Mutter, Tetrahedron Lett. 36, 229 (1995).
3. K. Rose, J. Am. Chem. Soc. 116, 30 (1994).
4. C.-F. Liu and J. P. Tam, Proc. Natl. Acad. Sci. U.S.A. 91, 6584 (1994).
5. J. Shao and J. P. Tam, J. Am. Chem. Soc. 117, 3893 (1995).
6. M. Schnölzer, P. Alewood, A. Jones, D. Alewood, and S. B. H. Kent, Intl. J. Pept. Protein Res. 40, 180 (1992).
7. H. Yajima and N. Fujii, J. Am. Chem. Soc. 103, 5867 (1981).
8. T. Kimura, M. Takai, T. Morikawa, and S. Sakakibara, in "Peptide Chemistry 1981" (T. Shioiri, ed.), p. 131. Protein Research Foundation, Osaka, Japan, 1981.
9. H. F. Gaertner, K. Rose, R. Cotton, D. Timms, R. Camble, and R. E. Offord, Bioconj. Chem. 3, 262 (1992).
10. M. Baca, T. W. Muir, M. Schnölzer, and S. B. H. Kent, J. Am. Chem. Soc. 117, 1881 (1995).
11. L. E. Canne, A. R. Ferre-D'Amare, S. K. Burley, and S. B. H. Kent, J. Am. Chem. Soc. 117, 2998 (1995).
12. M. J. Williams, T. W. Muir, M. H. Ginsberg, and S. B. H. Kent, J. Am. Chem. Soc. 116, 10797 (1994).
13. M. Mutter, G. G. Tuchscherer, C. Miller, K.-H. Altmann, R. I. Carey, D. F. Wyss, A. M. Labardt, and J. E. Rivier, J. Am. Chem. Soc. 114, 1463 (1992).
14. P. E. Dawson and S. B. H. Kent, J. Am. Chem. Soc. 115, 7263 (1993).
15. T. W. Muir, M. J. Williams, M. H. Ginsberg, and S. B. H. Kent, Biochemistry 33, 7701 (1994).
16. 18-20 These data formed the basis of the successful structure-based drug design programs that led to the highly effective protease inhibitor class of therapeutics for treatment of acquired immunodeficiency syndrome (AIDS).
17. J. Schneider and S. B. H. Kent, Cell (Cambridge, Mass.) 54, 363 (1988).
18. M. Miller, B. K. Sathyanarayana, M. V. Toth, G. R. Marshall, L. Clawson, L. Selk, J. Schneider, S. B. H. Kent, and A. Wlodawer, Science 246, 1149 (1989).
19. A. L. Swain, M. Miller, J. Green, D. H. Rich, J. Schneider, S. B. H. Kent, and A. Wlodawer, Proc. Natl. Acad. Sci. U.S.A. 87, 8805 (1990).
20. M. Jaskolski, A. G. Tomasselli, T. K. Sawyer, D. G. Staples, R. L. Heinrikson, J. Schneider, S. B. H. Kent, and A. Wlodawer, Biochemistry 30, 1600 (1991).
21. J. Cohen, Science 271, 755 (1996).
22. M. Baca and S. B. H. Kent, Proc. Natl. Acad. Sci. U.S.A. 90, 11638 (1993).
23. R. deLisle Milton, S. Milton, and S. B. H. Kent, in "Techniques in Protein Chemistry IV" (R. H. Angeletti, ed.), p. 257. Academic Press, New York, 1993.
24. M. Baca, Ph.D. Thesis, The Scripps Research Institute, 1994.
25. P. E. Dawson, T. W. Muir, I. Clark-Lewis, and S. B. H. Kent, Science 266, 776 (1994).
26. T. Wieland, in "The Roots of Modern Biochemistry" (V. D. Kleinkauf Jaeniche, ed.), p. 213. de Gruyter, Berlin and New York, 1988.
27. T. Wieland, E. Bokelmann, L. Bauer, H. U. Lang, and H. Lau, Liebigs Ann. Chem. 583, 129 (1953).
28. T. Wieland and G. Schneider, Liebigs Ann. Chem. 580, 159 (1953).
29. J. P. Tam, Y.-A. Lu, C.-F. Liu, and J. Shao, Proc. Natl. Acad. Sci. U.S.A. 92, 12485 (1995).
30. W. Lu, M. A. Qasim, and S. B. H. Kent, J. Am. Chem. Soc. 118, 8518 (1996).
31. P. E. Dawson, M. J. Churchill, M. R. Ghadiri, and S. B. H. Kent, J. Am. Chem. Soc. 119, 4325 (1997).
32. T. M. Hackeng, C. M. Mounier, C. Bon, P. E. Dawson, J. H. Griffin, and S. B. H. Kent, Proc. Natl. Acad. Sci. U.S.A. 94, in press (1997).
33. W. Lu, M. A. Qasim, M. Laskowski, and S. B. H. Kent, Biochemistry 36, 673 (1997).
34. P. Dawson, T. Muir, M. Fitzgerald, and S. B. H. Kent, in "Peptides 1996: Proceedings of the Twenty-fourth European Peptide Symposium, Edinburgh, September 1996" (R. Ramage, ed.), in press, 1997.
35. J. Blake and C. H. Li, Proc. Natl. Acad. Sci. U.S.A. 78, 4055 (1981).
36. D. Yamashiro and C. H. Li, Intl. J. Pept. Protein Res. 31, 322 (1988).
37. L. E. Canne, S. M. Walker, and S. B. H. Kent, Tetrahedron Lett. 36, 1217 (1995).
38. M. Schnölzer, A. Jones, P. F. Alewood, and S. B. H. Kent, Anal. Biochem. 204, 335 (1992).
39. L. Zhang and J. P. Tam, Tetrahedron Lett. 38, 3 (1997).
40. H. Hojo, C. Maegawa, S. Yoshimura, and S. Aimoto, in "Peptide Chemistry 1989" (N. Yanaihara, ed.), p. 297. Protein Research Foundation, Osaka, Japan, 1989.
41. S. B. H. Kent, Annu. Rev. Biochem. 57, 957 (1988).
42. J. F. Bazan, Proc. Natl. Acad. Sci. U.S.A. 87, 6934 (1990).
43. L. E. Canne, S. J. Bark, and S. B. H. Kent, J. Am. Chem. Soc. 118, 5891 (1996).
44. Tesser and I. C. Balvert-Geers, Int. J. Pept. Protein Res. 7, 295 (1975).
45. L. Zhang and J. P. Tam, J. Am. Chem. Soc. 119, 2363 (1997).
46. C.-F. Liu and J. P. Tam, J. Am. Chem. Soc. 116, 4149 (1994).
47. V. K. Sarin, S. B. H. Kent, J. P. Tam, and R. B. Merrifield, Anal. Biochem. 117, 147 (1981).